Overview Fundamentals API Earnings EOD API Sample Code Pricing

Dr. Reddy’s Laboratories Ltd ADR (RDY NYSE) stock market data APIs

$80.57 0.5(0.6%) as of July 24, 2024
Price chart is built with Anychart

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Dr. Reddy’s Laboratories Ltd ADR Financial Data Overview

80.07
80.57
-
81.01
79.95
63.3364-81.015
13 562 M
20.1241
167 M
279 164 M
0.0059
0.345
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RDY',
Type: 'Common Stock',
Name: 'Dr. Reddy’s Laboratories Ltd ADR',
Exchange: 'NYSE',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000NJ96L6',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'March',
IPODate: '2001-04-11',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: 'ADR',
IsDelisted: false,
}

Dr. Reddy’s Laboratories Ltd ADR Fundamental Data is available in our Financial Data APIs

  • Net Revenue 279 164 M
  • EBITDA 79 006 M
  • Earnings Per Share 3.99
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Dr. Reddy’s Laboratories Ltd ADR Earnings via APIs

  • Latest Release 2024-07-24
  • EPS/Forecast 0.91

Get Dr. Reddy’s Laboratories Ltd ADR End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com